Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Shirley V. Wang, Kueiyu Joshua Lin, Sebastian Schneeweiss |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Validation of alopecia coding in US claims data among women of childbearing age
par: Maria C. Schneeweiss, et autres
Publié: (2024)
par: Maria C. Schneeweiss, et autres
Publié: (2024)
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data
par: Joshua U. Okonkwo, et autres
Publié: (2025)
par: Joshua U. Okonkwo, et autres
Publié: (2025)
A Dynamic Prognostic Model for Identifying Vulnerable COVID‐19 Patients at High Risk of Rapid Deterioration
par: Priyanka Anand, et autres
Publié: (2024)
par: Priyanka Anand, et autres
Publié: (2024)
Validating claims‐based definitions for deprescribing: Bridging the gap between clinical and administrative data
par: Joshua D. Niznik, et autres
Publié: (2024)
par: Joshua D. Niznik, et autres
Publié: (2024)
An open‐source implementation of tree‐based scan statistics
par: Massimiliano Russo, et autres
Publié: (2024)
par: Massimiliano Russo, et autres
Publié: (2024)
Advancing Research Transparency and Reproducibility in Pharmacoepidemiology
par: Shirley V. Wang, et autres
Publié: (2025)
par: Shirley V. Wang, et autres
Publié: (2025)
A Plasmode Simulation‐Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information‐Rich Subsets
par: Rishi J. Desai, et autres
Publié: (2026)
par: Rishi J. Desai, et autres
Publié: (2026)
Preregistration: A Key to Credible Real‐World Evidence Generation
par: Emma Simonsen, et autres
Publié: (2025)
par: Emma Simonsen, et autres
Publié: (2025)
Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing–remitting multiple sclerosis?
par: Stefan Verweij, et autres
Publié: (2024)
par: Stefan Verweij, et autres
Publié: (2024)
Resumption of Antiplatelet Therapy After Burr‐Hole Surgery and Recurrence in Patients With Chronic Subdural Hematoma: A Target Trial Emulation
par: Takayuki Anno, et autres
Publié: (2026)
par: Takayuki Anno, et autres
Publié: (2026)
Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus
par: Charles E. Gaber, et autres
Publié: (2024)
par: Charles E. Gaber, et autres
Publié: (2024)
Vancomycin‐Induced Acute Kidney Injury in Intensive Care Patients: A Target Trial Emulation Study Using Multicenter Routinely Collected Data
par: Izak A. R. Yasrebi‐de Kom, et autres
Publié: (2025)
par: Izak A. R. Yasrebi‐de Kom, et autres
Publié: (2025)
Comparing survival in trial‐ versus routine‐care advanced urothelial cancer patients on immune checkpoint blockade
par: Lucy S. Wang, et autres
Publié: (2024)
par: Lucy S. Wang, et autres
Publié: (2024)
An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer
par: Jessica A. Perhanidis, et autres
Publié: (2024)
par: Jessica A. Perhanidis, et autres
Publié: (2024)
The FDA Sentinel Real World Evidence Data Enterprise (RWE‐DE)
par: Rishi J. Desai, et autres
Publié: (2024)
par: Rishi J. Desai, et autres
Publié: (2024)
Comparative Survival of First‐Line Immunotherapy Plus Chemotherapy Versus Immunotherapy Monotherapy in Older Adults With Metastatic Non‐Small Cell Lung Cancer: An Emulated Target Trial Approach
par: Xiangzhong Xue, et autres
Publié: (2026)
par: Xiangzhong Xue, et autres
Publié: (2026)
Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998–2019): A population‐based assessment
par: Reem Masarwa, et autres
Publié: (2024)
par: Reem Masarwa, et autres
Publié: (2024)
Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings
par: Karilynn M. Rockhill, et autres
Publié: (2025)
par: Karilynn M. Rockhill, et autres
Publié: (2025)
Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy
par: Yu‐Ri Choi, et autres
Publié: (2025)
par: Yu‐Ri Choi, et autres
Publié: (2025)
Clarifying the causal contrast: An empirical example applying the prevalent new user study design
par: Jessica C. Young, et autres
Publié: (2024)
par: Jessica C. Young, et autres
Publié: (2024)
Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment
par: Brianna Costales, et autres
Publié: (2024)
par: Brianna Costales, et autres
Publié: (2024)
Dipeptidyl Peptidase‐4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease Requiring Dialysis
par: Tzu‐Han Lin, et autres
Publié: (2025)
par: Tzu‐Han Lin, et autres
Publié: (2025)
Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review
par: Shahd A. Ageeb, et autres
Publié: (2024)
par: Shahd A. Ageeb, et autres
Publié: (2024)
A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy
par: Matthew R. Muschett, et autres
Publié: (2024)
par: Matthew R. Muschett, et autres
Publié: (2024)
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis
par: Kyoko Saito, et autres
Publié: (2024)
par: Kyoko Saito, et autres
Publié: (2024)
Medicine utilization studies in Australian individual‐level dispensing data: A blinded, multi‐center replicated analysis
par: Malcolm B. Gillies, et autres
Publié: (2024)
par: Malcolm B. Gillies, et autres
Publié: (2024)
Factors Associated With Self‐Medication to Mitigate Vaccine Reactions After COVID ‐19 Vaccination: A Prospective Cohort Study
par: Maximilian Blattner, et autres
Publié: (2026)
par: Maximilian Blattner, et autres
Publié: (2026)
Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program
par: Stefan de Vogel, et autres
Publié: (2024)
par: Stefan de Vogel, et autres
Publié: (2024)
Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A post‐authorization safety study
par: Soulmaz Fazeli Farsani, et autres
Publié: (2024)
par: Soulmaz Fazeli Farsani, et autres
Publié: (2024)
Prescriber Adherence to Antihypertensive Prescription Guidelines and the Impact of Patient Socioeconomic Factors: A Cross‐Sectional Study Using Data From the Irish Longitudinal Study on Ageing
par: Alizeh Akhtar, et autres
Publié: (2024)
par: Alizeh Akhtar, et autres
Publié: (2024)
Adverse Events Associated With Dabrafenib, Trametinib, and Their Combination Therapy: A Disproportionality Analysis of the FDA Adverse Event Reporting System ( FAERS ) Database
par: Zhenpo Zhang, et autres
Publié: (2025)
par: Zhenpo Zhang, et autres
Publié: (2025)
Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries
par: Wendy Wang, et autres
Publié: (2024)
par: Wendy Wang, et autres
Publié: (2024)
Identifying Patients With Primary Biliary Cholangitis and Cirrhosis Using Administrative Data in a National Cohort
par: Binu V. John, et autres
Publié: (2024)
par: Binu V. John, et autres
Publié: (2024)
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real‐world data
par: Paul Muntner, et autres
Publié: (2024)
par: Paul Muntner, et autres
Publié: (2024)
Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI)
par: Dinci Pennap, et autres
Publié: (2024)
par: Dinci Pennap, et autres
Publié: (2024)
Medication‐related incidents in acute care hospitals among different age groups: An analysis of national patient safety report data
par: Ji Min Han, et autres
Publié: (2024)
par: Ji Min Han, et autres
Publié: (2024)
Use of electronic health record data to examine administrations of pro re nata analgesics during hip fracture post‐acute care
par: Melissa R. Riester, et autres
Publié: (2024)
par: Melissa R. Riester, et autres
Publié: (2024)
Where are the data to assess the safety of paternal drug exposure? A systematic review of secondary databases: A contribution from IMI concePTION
par: Sneha Gaitonde, et autres
Publié: (2024)
par: Sneha Gaitonde, et autres
Publié: (2024)
A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis‐Related Safety Signals
par: Priscilla O. M. V. Lopes, et autres
Publié: (2026)
par: Priscilla O. M. V. Lopes, et autres
Publié: (2026)
The Impact of Balance Solution on the Outcomes of Incident Peritoneal Dialysis Patients
par: I‐Kuan Wang, et autres
Publié: (2026)
par: I‐Kuan Wang, et autres
Publié: (2026)
Documents similaires
-
Validation of alopecia coding in US claims data among women of childbearing age
par: Maria C. Schneeweiss, et autres
Publié: (2024) -
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data
par: Joshua U. Okonkwo, et autres
Publié: (2025) -
A Dynamic Prognostic Model for Identifying Vulnerable COVID‐19 Patients at High Risk of Rapid Deterioration
par: Priyanka Anand, et autres
Publié: (2024) -
Validating claims‐based definitions for deprescribing: Bridging the gap between clinical and administrative data
par: Joshua D. Niznik, et autres
Publié: (2024) -
An open‐source implementation of tree‐based scan statistics
par: Massimiliano Russo, et autres
Publié: (2024)